摘要
Renal cell carcinoma (RCC) is one of the most important urological tumors and is one of the most common cancer diseases worldwide. Unfortunately, the treatment options are very limited due to resistances. Non-invasive physical plasma (NIPP) is currently becoming a promising and very well tolerated treatment option for cancer. NIPP represents a highly energized gas and induc</span><span style="font-family:Verdana;">es varying antioncogenic cell responses in tumor cells. And also in t</span><span style="font-family:Verdana;">he case of RCC, NIPP treatment has great potential to enhance and supplement existing anticancer treatment options. Outstanding characteristics of NIPP treatment are 1) a precise and local effect on the treated tissue and 2) an almost exclusive effect on treated tumor cells without side effects. This allows </span><span style="font-family:Verdana;">an enormously large therapeutic window and makes the combination o</span><span style="font-family:Verdana;">f NIPP treatment and classical therapy appear particularly promising. In addition to R</span><span style="font-family:Verdana;">CC, plasma oncology offers an extremely innovative physical treatme</span><span style="font-family:Verdana;">nt method for future oncology in general.</span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">This brief review article summarizes the current knowledge on the potential use of NIPP in RCC therapy.
Renal cell carcinoma (RCC) is one of the most important urological tumors and is one of the most common cancer diseases worldwide. Unfortunately, the treatment options are very limited due to resistances. Non-invasive physical plasma (NIPP) is currently becoming a promising and very well tolerated treatment option for cancer. NIPP represents a highly energized gas and induc</span><span style="font-family:Verdana;">es varying antioncogenic cell responses in tumor cells. And also in t</span><span style="font-family:Verdana;">he case of RCC, NIPP treatment has great potential to enhance and supplement existing anticancer treatment options. Outstanding characteristics of NIPP treatment are 1) a precise and local effect on the treated tissue and 2) an almost exclusive effect on treated tumor cells without side effects. This allows </span><span style="font-family:Verdana;">an enormously large therapeutic window and makes the combination o</span><span style="font-family:Verdana;">f NIPP treatment and classical therapy appear particularly promising. In addition to R</span><span style="font-family:Verdana;">CC, plasma oncology offers an extremely innovative physical treatme</span><span style="font-family:Verdana;">nt method for future oncology in general.</span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">This brief review article summarizes the current knowledge on the potential use of NIPP in RCC therapy.
作者
Andreas Nitsch
Matthias Bernhard Stope
Andreas Nitsch;Matthias Bernhard Stope(Department of Trauma, Reconstructive Surgery and Rehabilitation Medicine, University Medicine Greifswald, Greifswald, Germany;Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany)
